Yong-Mi Kim, MD, PhD

Professor of Pediatrics

Image of Yong-Mi Kim, MD, PhD
Is this your profile? Click to edit

Publications

  • IFN-γ drives long-term bone marrow niche dysfunction following doxorubicin-based chemotherapy. Blood. 2026 09 03; 148(10):1277-1291.. View in PubMed
  • Integrin Alpha 4 Inhibition Prolongs the Survival of NSG Mice Engrafted with CD19-Negative Post-CART19 Relapsed B-ALL. Exp Hematol. 2026 Sep; 161:105471.. View in PubMed
  • Author Correction: BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. Nature. 2026 Mar; 651(8104):E3.. View in PubMed
  • Targeting Wnt Signaling in Acute Lymphoblastic Leukemia. Cancers (Basel). 2025 Jul 24; 17(15).. View in PubMed
  • CD33-CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T Cells. Blood Cancer Discov. 2025 01 08; 6(1):55-72.. View in PubMed
  • Wnt Signaling in the Tumor Microenvironment. Adv Exp Med Biol. 2021; 1270:107-121.. View in PubMed
  • Cadherins, Selectins, and Integrins in CAM-DR in Leukemia. Front Oncol. 2020; 10:592733.. View in PubMed
  • Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment. Int J Mol Sci. 2020 Aug 28; 21(17).. View in PubMed
  • Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia. Blood. 2020 07 09; 136(2):210-223.. View in PubMed
  • Characterizing the Motility of Chemotherapeutics-Treated Acute Lymphoblastic Leukemia Cells by Time-Lapse Imaging. Cells. 2020 06 16; 9(6).. View in PubMed